Early-Phase 18 F-Florbetapir and 18 F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting
Journal of Nuclear Medicine · 2023-02 · 64 (2) · 266-273
DOI: 10.2967/jnumed.122.264256 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 21.07.2022. Verfasst von Cecilia Boccalini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Vita-Salute San Raffaele University, Italy. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Alzheimer's disease (AD) neuropathologic changes are β-amyloid (Aβ) deposition, pathologic tau, and neurodegeneration. Dual-phase amyloid-PET might be able to evaluate Aβ deposition and neurodegeneration with a single tracer injection. Early-phase amyloid-PET scans provide a proxy for cerebral perfusion, which has shown good correlations with neural dysfunction measured through metabolic consumption, while the late frames depict amyloid distribution. Our study aims to assess the comparability between early-phase amyloid-PET scans and 18F-fluorodeoxyglucose (18F-FDG)-PET brain topography at the individual level, and their ability to discriminate patients.
Methods
166 subjects evaluated at the Geneva Memory Center, ranging from cognitively unimpaired to Mild Cognitive Impairment (MCI) and dementia, underwent early-phase amyloid-PET - using either 18F-florbetapir (eFBP) (n = 94) or 18F-flutemetamol (eFMM) (n = 72) - and 18F-FDG-PET. Aβ status was assessed. Standardized uptake value ratios (SUVR) were extracted to evaluate the correlation of eFBP/eFMM and their respective 18F-FDG-PET scans. The single-subject procedure was applied to investigate hypometabolism and hypoperfusion maps and their spatial overlap by Dice coefficient. Receiver operating characteristic analyses were performed to compare the discriminative power of eFBP/eFMM, and 18F-FDG-PET SUVR in AD-related metaROI between Aβ-negative healthy controls and cases in the AD continuum.
Results
Positive correlations were found between eFBP/eFMM and 18F-FDG-PET SUVR independently of Aβ status and Aβ radiotracer (R>0.72, p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Vita-Salute San Raffaele University, Italy.
- University of Geneva, Switzerland.
- Geneva University Hospitals, Switzerland.
- University Hospitals of Geneva.
- Vita-Salute San Raffaele University Milan, Italy.
- Geneva University and Geneva University Hospital, Switzerland.
Zitieren
APA
Boccalini, C., Peretti, D. E., Ribaldi, F., Scheffler, M., Stampacchia, S., Tomczyk, S., Rodriguez, C., Montandon, M. L., Haller, S., Giannakopoulos, P., Frisoni, G. B., Perani, D., & Garibotto, V. (2023). Early-Phase 18 F-Florbetapir and 18 F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting. Journal of Nuclear Medicine, 64(2), 266-273. https://doi.org/10.2967/jnumed.122.264256
Vancouver
Boccalini C, Peretti DE, Ribaldi F, Scheffler M, Stampacchia S, Tomczyk S, et al. Early-Phase 18 F-Florbetapir and 18 F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting. Journal of Nuclear Medicine. 2023;64(2):266-273. doi:10.2967/jnumed.122.264256
BibTeX
@article{Boccalini2023,
author = {Boccalini, Cecilia and Peretti, Debora Elisa and Ribaldi, Federica and Scheffler, Max and Stampacchia, Sara and Tomczyk, Szymon and Rodriguez, Cristelle and Montandon, Marie Louise and Haller, Sven and Giannakopoulos, Panteleimon and Frisoni, Giovanni Battista and Perani, Daniela and Garibotto, Valentina},
title = {Early-Phase 18 F-Florbetapir and 18 F-Flutemetamol Images as Proxies of Brain Metabolism in a Memory Clinic Setting},
journal = {Journal of Nuclear Medicine},
year = {2023},
volume = {64},
number = {2},
pages = {266--273},
doi = {10.2967/jnumed.122.264256}
}
EUVIMED